Steven F. Francom

A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration

David S. Boyer, Jeffrey S. Heier, David M. Brown et al. · Ophthalmology · 2009 · 344 citations

Ocular Disease, Experimental Ophthalmology, Ophthalmology +3

Pharmacokinetics and pharmacodynamics of oral diazepam: Effect of dose, plasma concentration, and time

H. Friedman, David J. Greenblatt, Gary Peters et al. · Clinical Pharmacology & Therapeutics · 1992 · 100 citations

Electrocardiographic Identification of Drug‐Induced QT Prolongation: Assessment by Different Recording and Measurement Methods

Nenad Sarapa, Joel Morganroth, Jean‐Philippe Couderc et al. · Annals of Noninvasive Electrocardiology · 2004 · 95 citations · Full text

Pharmacotherapy, Manual Digipad, Medical Instrumentation +19

CEREBROVASCULAR ACCIDENTS IN PATIENTS TREATED FOR CHOROIDAL NEOVASCULARIZATION WITH RANIBIZUMAB IN RANDOMIZED CONTROLLED TRIALS

Neil M. Bressler, David S. Boyer, David F. Williams et al. · Retina · 2012 · 88 citations

Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans*

George S. Hughes, Elizabeth P. Yancey, Rodney Albrecht et al. · Clinical Pharmacology & Therapeutics · 1995 · 69 citations